OKUR vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

OKUR

51.5
AI Score
VS
OKUR Wins

CBIO

38.0
AI Score

Investment Advisor Scores

OKUR

52score
Recommendation
HOLD

CBIO

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric OKUR CBIO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 0.0% Tie
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 51.5/100 38.0/100 OKUR
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL OKUR

Relative Price Performance (Last 90 Days)

OKUR 1M: -6.6% · 3M: -3.2% CBIO 1M: +0.7% · 3M: -15.2%

Current Technical Phase

OKUR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.4 · Price: $3.94

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $17.15

Fundamentals Snapshot

Metric OKUR CBIO
Market Cap
Forward P/E -2.6 -6.5
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 1.0%
Operating Margin 0.0% -14.3%
EPS -2.91 -0.13
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, OKUR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.